Analyst Price Targets — ATXI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 7, 2024 7:52 am | Jason McCarthy | Maxim Group | $12.00 | $3.39 | StreetInsider | Avenue Therapeutics (ATXI) PT Lowered to $12 at Maxim Group |
Latest News for ATXI
Avenue Therapeutics (NASDAQ:ATXI) and Collegium Pharmaceutical (NASDAQ:COLL) Head-To-Head Survey
Collegium Pharmaceutical (NASDAQ: COLL - Get Free Report) and Avenue Therapeutics (NASDAQ: ATXI - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership. Profitability This table compares Collegium Pharmaceutical…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATXI.
U.S. House Trading
No House trades found for ATXI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.